comparemela.com

Latest Breaking News On - Volker koscielny - Page 4 : comparemela.com

Almirall's 'Moving aheAD' campaign adapts famous art to raise atopic dermatitis awareness

Almirall's 'Moving aheAD' campaign adapts famous art to raise atopic dermatitis awareness
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Spain
Spanish
Las-meninas
Mona-lisa
Volker-koscielny
Johannes-vermeer
Kristen-dowd
Atopic-museum
European-union
World-atopic-eczema-day
Industry-news
Diego-vel

World Atopic Eczema Day 2023: Almirall unveils awareness campaign

World Atopic Eczema Day 2023: Almirall unveils awareness campaign
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Spain
Spanish
Vinci-mona-lisa
Volker-koscielny
European-federation-of-allergy
Atopical-museum
Airways-diseases-patient-associations
World-atopic-eczema-day
Atopical-museum
Mona-lisa
Luca-de-tena
Atopic-eczema-day

Almirall's Ilumetri shown to improve well-being of patients with plaque psoriasis

Almirall's Ilumetri shown to improve well-being of patients with plaque psoriasis
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Singapore
Volker-koscielny
Frida-dunger-johnsson
World-health-organization
World-congress
International-federation-of-psoriatic-disease-associations
Well-being-index
Dunger-johnsson
International-federation
Psoriatic-disease-associations

Almirall: Ilumetri (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

Almirall: Ilumetri (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Singapore
Spain
Italy
Switzerland
Netherlands
Austria
Barcelona
Comunidad-autonoma-de-cataluna
France
Germany
Belgium
United-kingdom

Almirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasis

At the 25th World Congress of Dermatology Tildrakizumab also significantly improved skin symptoms and quality of life in patients with moderate to severe plaque psoriasis after 28 weeks in a real-world setting and with a safety profile consistent with randomized phase III clinical trials1,2 Almirall has shown for the first time that the wellbeing of patients with moderate to severe plaque psoriasis at baseline was comparable to the level of wellbeing found in other diseases3 such as breast cancer4 Preliminary results of the POSITIVE study demonstrate the company s commitment to addressing unmet needs in the treatment of patients with psoriasis

Singapore
Spain
Switzerland
Italy
United-kingdom
Austria
Barcelona
Comunidad-autonoma-de-cataluna
Germany
Belgium
France
Netherlands

vimarsana © 2020. All Rights Reserved.